{"id":"https://openalex.org/W2019845453","doi":"https://doi.org/10.1016/j.chemolab.2004.02.007","title":"Multivariate adaptive regression splines\u2014studies of HIV reverse transcriptase inhibitors","display_name":"Multivariate adaptive regression splines\u2014studies of HIV reverse transcriptase inhibitors","publication_year":2004,"publication_date":"2004-04-24","ids":{"openalex":"https://openalex.org/W2019845453","doi":"https://doi.org/10.1016/j.chemolab.2004.02.007","mag":"2019845453"},"language":"en","primary_location":{"id":"doi:10.1016/j.chemolab.2004.02.007","doi":"https://doi.org/10.1016/j.chemolab.2004.02.007","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.chemolab.2004.02.007","pdf_url":null,"source":{"id":"https://openalex.org/S69755223","display_name":"Chemometrics and Intelligent Laboratory Systems","issn_l":"0169-7439","issn":["0169-7439","1873-3239"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Chemometrics and Intelligent Laboratory Systems","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100763750","display_name":"Qingsong Xu","orcid":"https://orcid.org/0000-0002-1700-322X","observed_orcids":["https://orcid.org/0000-0002-1700-322X","https://orcid.org/0000-0001-6898-0269"]},"institutions":[{"id":"https://openalex.org/I13469542","display_name":"Vrije Universiteit Brussel","ror":"https://ror.org/006e5kg04","country_code":"BE","type":"education","lineage":["https://openalex.org/I13469542"]},{"id":"https://openalex.org/I16609230","display_name":"Hunan University","ror":"https://ror.org/05htk5m33","country_code":"CN","type":"education","lineage":["https://openalex.org/I16609230"]}],"countries":["BE","CN"],"is_corresponding":false,"raw_author_name":"Q.-S. Xu","raw_affiliation_strings":["FABI, ChemoAC, Vrije Universiteit Brussels, Laarbeeklaan 103, Brussels B-1090, Belgium","on leave from Hunan University, Changsha 410082, PR China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"FABI, ChemoAC, Vrije Universiteit Brussels, Laarbeeklaan 103, Brussels B-1090, Belgium","institution_ids":["https://openalex.org/I13469542"]},{"raw_affiliation_string":"on leave from Hunan University, Changsha 410082, PR China","institution_ids":["https://openalex.org/I16609230"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033422740","display_name":"Micha\u0142 Daszykowski","orcid":"https://orcid.org/0000-0003-0275-2751","observed_orcids":["https://orcid.org/0000-0003-0275-2751"]},"institutions":[{"id":"https://openalex.org/I13469542","display_name":"Vrije Universiteit Brussel","ror":"https://ror.org/006e5kg04","country_code":"BE","type":"education","lineage":["https://openalex.org/I13469542"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"M. Daszykowski","raw_affiliation_strings":["FABI, ChemoAC, Vrije Universiteit Brussels, Laarbeeklaan 103, Brussels B-1090, Belgium","on leave from Silesian University, 9 Szkolna Street, Katowice 40-006, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"FABI, ChemoAC, Vrije Universiteit Brussels, Laarbeeklaan 103, Brussels B-1090, Belgium","institution_ids":["https://openalex.org/I13469542"]},{"raw_affiliation_string":"on leave from Silesian University, 9 Szkolna Street, Katowice 40-006, Poland","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039521338","display_name":"Beata Walczak","orcid":"https://orcid.org/0000-0002-6909-6333","observed_orcids":["https://orcid.org/0000-0002-6909-6333"]},"institutions":[{"id":"https://openalex.org/I13469542","display_name":"Vrije Universiteit Brussel","ror":"https://ror.org/006e5kg04","country_code":"BE","type":"education","lineage":["https://openalex.org/I13469542"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"B. Walczak","raw_affiliation_strings":["FABI, ChemoAC, Vrije Universiteit Brussels, Laarbeeklaan 103, Brussels B-1090, Belgium","on leave from Silesian University, 9 Szkolna Street, Katowice 40-006, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"FABI, ChemoAC, Vrije Universiteit Brussels, Laarbeeklaan 103, Brussels B-1090, Belgium","institution_ids":["https://openalex.org/I13469542"]},{"raw_affiliation_string":"on leave from Silesian University, 9 Szkolna Street, Katowice 40-006, Poland","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113595535","display_name":"Frits F. D. Daeyaert","orcid":"https://orcid.org/0009-0000-7405-056X","observed_orcids":["https://orcid.org/0009-0000-7405-056X"]},"institutions":[{"id":"https://openalex.org/I137982388","display_name":"Janssen (Belgium)","ror":"https://ror.org/04yzcpd71","country_code":"BE","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I137982388"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"F. Daeyaert","raw_affiliation_strings":["Center for Molecular Design, Janssen Pharmaceutica N.V., Antwerpsesteenweg 37, B-2350, Vosselaar, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Molecular Design, Janssen Pharmaceutica N.V., Antwerpsesteenweg 37, B-2350, Vosselaar, Belgium","institution_ids":["https://openalex.org/I137982388"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008765554","display_name":"Marc R. de Jonge","orcid":"https://orcid.org/0000-0003-3225-8172","observed_orcids":["https://orcid.org/0000-0003-3225-8172"]},"institutions":[{"id":"https://openalex.org/I137982388","display_name":"Janssen (Belgium)","ror":"https://ror.org/04yzcpd71","country_code":"BE","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I137982388"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"M.R. de Jonge","raw_affiliation_strings":["Center for Molecular Design, Janssen Pharmaceutica N.V., Antwerpsesteenweg 37, B-2350, Vosselaar, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Molecular Design, Janssen Pharmaceutica N.V., Antwerpsesteenweg 37, B-2350, Vosselaar, Belgium","institution_ids":["https://openalex.org/I137982388"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046188438","display_name":"Jan Heeres","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I137982388","display_name":"Janssen (Belgium)","ror":"https://ror.org/04yzcpd71","country_code":"BE","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I137982388"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"J. Heeres","raw_affiliation_strings":["Center for Molecular Design, Janssen Pharmaceutica N.V., Antwerpsesteenweg 37, B-2350, Vosselaar, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Molecular Design, Janssen Pharmaceutica N.V., Antwerpsesteenweg 37, B-2350, Vosselaar, Belgium","institution_ids":["https://openalex.org/I137982388"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108409175","display_name":"Luc M. H. Koymans","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I137982388","display_name":"Janssen (Belgium)","ror":"https://ror.org/04yzcpd71","country_code":"BE","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I137982388"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"L.M.H. Koymans","raw_affiliation_strings":["Center for Molecular Design, Janssen Pharmaceutica N.V., Antwerpsesteenweg 37, B-2350, Vosselaar, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Molecular Design, Janssen Pharmaceutica N.V., Antwerpsesteenweg 37, B-2350, Vosselaar, Belgium","institution_ids":["https://openalex.org/I137982388"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052131378","display_name":"Paul J Lewi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I137982388","display_name":"Janssen (Belgium)","ror":"https://ror.org/04yzcpd71","country_code":"BE","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I137982388"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"P.J. Lewi","raw_affiliation_strings":["Center for Molecular Design, Janssen Pharmaceutica N.V., Antwerpsesteenweg 37, B-2350, Vosselaar, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Molecular Design, Janssen Pharmaceutica N.V., Antwerpsesteenweg 37, B-2350, Vosselaar, Belgium","institution_ids":["https://openalex.org/I137982388"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087408119","display_name":"H. Maarten Vinkers","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I137982388","display_name":"Janssen (Belgium)","ror":"https://ror.org/04yzcpd71","country_code":"BE","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I137982388"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"H.M. Vinkers","raw_affiliation_strings":["Center for Molecular Design, Janssen Pharmaceutica N.V., Antwerpsesteenweg 37, B-2350, Vosselaar, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Molecular Design, Janssen Pharmaceutica N.V., Antwerpsesteenweg 37, B-2350, Vosselaar, Belgium","institution_ids":["https://openalex.org/I137982388"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103427054","display_name":"Paul A. J. Janssen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I137982388","display_name":"Janssen (Belgium)","ror":"https://ror.org/04yzcpd71","country_code":"BE","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I137982388"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"P.A. Janssen","raw_affiliation_strings":["Center for Molecular Design, Janssen Pharmaceutica N.V., Antwerpsesteenweg 37, B-2350, Vosselaar, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Molecular Design, Janssen Pharmaceutica N.V., Antwerpsesteenweg 37, B-2350, Vosselaar, Belgium","institution_ids":["https://openalex.org/I137982388"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111699139","display_name":"D.L. Massart","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I13469542","display_name":"Vrije Universiteit Brussel","ror":"https://ror.org/006e5kg04","country_code":"BE","type":"education","lineage":["https://openalex.org/I13469542"]}],"countries":["BE"],"is_corresponding":true,"raw_author_name":"D.L. Massart","raw_affiliation_strings":["FABI, ChemoAC, Vrije Universiteit Brussels, Laarbeeklaan 103, Brussels B-1090, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"FABI, ChemoAC, Vrije Universiteit Brussels, Laarbeeklaan 103, Brussels B-1090, Belgium","institution_ids":["https://openalex.org/I13469542"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5111699139"],"corresponding_institution_ids":["https://openalex.org/I13469542"],"apc_list":{"value":3970,"currency":"USD","value_usd":3970},"apc_paid":null,"fwci":0.3003,"has_fulltext":false,"cited_by_count":52,"citation_normalized_percentile":{"value":0.45781893,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":99},"biblio":{"volume":"72","issue":"1","first_page":"27","last_page":"34"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.9883000254631042,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.9883000254631042,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.006000000052154064,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13141","display_name":"Statistical Methods and Applications","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/multivariate-adaptive-regression-splines","display_name":"multivariate adaptive regression splines","score":0.9819999933242798},{"id":"https://openalex.org/keywords/non-nucleoside-reverse-transcriptase-inhibitors","display_name":"non-nucleoside reverse transcriptase inhibitors","score":0.9909999966621399},{"id":"https://openalex.org/keywords/hiv-1","display_name":"HIV-1","score":0.8939999938011169},{"id":"https://openalex.org/keywords/qsar-modeling","display_name":"QSAR models","score":0.6079999804496765}],"concepts":[{"id":"https://openalex.org/C44882253","wikidata":"https://www.wikidata.org/wiki/Q3455882","display_name":"Multivariate adaptive regression splines","level":4,"score":0.8736556172370911},{"id":"https://openalex.org/C156719811","wikidata":"https://www.wikidata.org/wiki/Q28774","display_name":"Reverse transcriptase","level":4,"score":0.7484487295150757},{"id":"https://openalex.org/C161584116","wikidata":"https://www.wikidata.org/wiki/Q1952580","display_name":"Multivariate statistics","level":2,"score":0.5878936648368835},{"id":"https://openalex.org/C83260615","wikidata":"https://www.wikidata.org/wiki/Q6773121","display_name":"Mars Exploration Program","level":2,"score":0.5538470149040222},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.5469810962677002},{"id":"https://openalex.org/C2777351918","wikidata":"https://www.wikidata.org/wiki/Q421559","display_name":"Reverse-transcriptase inhibitor","level":5,"score":0.4777640402317047},{"id":"https://openalex.org/C2909970146","wikidata":"https://www.wikidata.org/wiki/Q421559","display_name":"Nucleoside Reverse Transcriptase Inhibitor","level":5,"score":0.4578148424625397},{"id":"https://openalex.org/C83546350","wikidata":"https://www.wikidata.org/wiki/Q1139051","display_name":"Regression","level":2,"score":0.39598608016967773},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3402329683303833},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.3314366340637207},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.2908555865287781},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.23049461841583252},{"id":"https://openalex.org/C105795698","wikidata":"https://www.wikidata.org/wiki/Q12483","display_name":"Statistics","level":1,"score":0.1472509801387787},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.12576499581336975},{"id":"https://openalex.org/C74127309","wikidata":"https://www.wikidata.org/wiki/Q3455886","display_name":"Nonparametric regression","level":3,"score":0.12344497442245483},{"id":"https://openalex.org/C2776452011","wikidata":"https://www.wikidata.org/wiki/Q311463","display_name":"Sida","level":4,"score":0.08280879259109497},{"id":"https://openalex.org/C67705224","wikidata":"https://www.wikidata.org/wiki/Q11053","display_name":"RNA","level":3,"score":0.08200511336326599},{"id":"https://openalex.org/C2780727368","wikidata":"https://www.wikidata.org/wiki/Q1928978","display_name":"Viral disease","level":3,"score":0.0758797824382782},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.06744071841239929},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.06194835901260376},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C87355193","wikidata":"https://www.wikidata.org/wiki/Q411","display_name":"Astrobiology","level":1,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1016/j.chemolab.2004.02.007","doi":"https://doi.org/10.1016/j.chemolab.2004.02.007","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.chemolab.2004.02.007","pdf_url":null,"source":{"id":"https://openalex.org/S69755223","display_name":"Chemometrics and Intelligent Laboratory Systems","issn_l":"0169-7439","issn":["0169-7439","1873-3239"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Chemometrics and Intelligent Laboratory Systems","raw_type":"journal-article"},{"id":"pmh:oai:vubissmart:VUBISSMART:2000:22859","doi":null,"is_oa":false,"landing_page_url":"https://biblio.vub.ac.be/vubir/multivariate-adaptive-regression-splines--studies-of-hiv-reverse-transcriptase-inhibitors(fcc00fdc-9e04-425a-b2d9-827818c35bba).html","pdf_url":null,"source":{"id":"https://openalex.org/S4306402573","display_name":"VUBIR (Vrije Universiteit Brussel)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I13469542","host_organization_name":"Vrije Universiteit Brussel","host_organization_lineage":["https://openalex.org/I13469542"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.504800021648407,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":35,"referenced_works":["https://openalex.org/W242257288","https://openalex.org/W1521042556","https://openalex.org/W1538011504","https://openalex.org/W1579198272","https://openalex.org/W1968071118","https://openalex.org/W1968922060","https://openalex.org/W1984094176","https://openalex.org/W1984814223","https://openalex.org/W1989685284","https://openalex.org/W1991715599","https://openalex.org/W1994126845","https://openalex.org/W1997957113","https://openalex.org/W2010551096","https://openalex.org/W2019980219","https://openalex.org/W2040679107","https://openalex.org/W2043674824","https://openalex.org/W2063381239","https://openalex.org/W2066074388","https://openalex.org/W2067599110","https://openalex.org/W2077036660","https://openalex.org/W2080443424","https://openalex.org/W2085302726","https://openalex.org/W2085312881","https://openalex.org/W2102098015","https://openalex.org/W2102201073","https://openalex.org/W2103766655","https://openalex.org/W2116844530","https://openalex.org/W2126340181","https://openalex.org/W2134713579","https://openalex.org/W2153689927","https://openalex.org/W2160753576","https://openalex.org/W2330820318","https://openalex.org/W3000332379","https://openalex.org/W3085162807","https://openalex.org/W4231419782"],"related_works":["https://openalex.org/W2069764132","https://openalex.org/W2046925747","https://openalex.org/W2141229355","https://openalex.org/W1992813516","https://openalex.org/W2073041844","https://openalex.org/W7170169474","https://openalex.org/W2080560949","https://openalex.org/W2163099275","https://openalex.org/W2035232364","https://openalex.org/W2066103483"],"abstract_inverted_index":null,"counts_by_year":[{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":7},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":4},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}